SUN PHARMA AT LONG TIME RESISTANCESunpharma is in important resistance level. The breakout can decide the direction.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
46.05 INR
95.76 B INR
478.63 B INR
1.02 B
About SUN PHARMACEUTICAL IND L
Sector
CEO
Dilip Shantilal Shanghvi
Headquarters
Mumbai
Website
Founded
1983
ISIN
INE044A01036
FIGI
BBG000BV5H87
Sun Pharmaceutical Industries Ltd. engages in manufacturing, developing, and marketing of pharmaceuticals products. It offers tablets, capsules, injectable, inhalers, ointments, creams, and liquids. The company was founded by Dilip Shantilal Shanghvi in 1983 and is headquartered in Mumbai, India.
SUNPHARMA - BREAKOUT RETEST or END of 5th?SUNPHARMA - CMP 1747
It appears that a 5 wave impulse from Covid lows (312) has ended at 1960
Primary and internal counts are marked in the chart
If it is too early to predict/expect a larger retracement of the entire move, lets take one step at a time and look for the price action from May'23 lo
sunpharma going to 1700 buy this srcript , very strong downffall ,
aftere breaking trendline and it is very confident move ahead
SUNPHARMA - Breakdown?There is tension on the support trendline. However, the price action seems to be weakening.
If a breakdown is witnessed, I expect some correction here in the short term.
Consolidation at ATHThe Stock and the Sector are both outperforming thr Benchmark. A Perfect Flag and Pole when broken may give a good run above the ATH
Stock at all time high (SUNPHARMA)SUNPHARMA 👑👑
Stock at all time high
In previous week stock formed a
DOJI and this week a breakout is
to be seen
Target 2200
Stop loss 1830
My personal opinion
SUNPHARMA // levels // 1dSUNPHARMA
looking good
Support Levels:
1,870 INR:
1,850 INR:
Resistance Levels:
1,905 INR:
1,920 INR:
Short SunpharmaWith lower time frame confirmation, we can short the sunpharma. This is for educational purposes only.
on Edge of Trend Termination Friends
This kind of structure do not hold for long time , they will eventually brake down after Long
Bull run
Now its true that it can brake out form Channel in Upside , but Probability of Making New high with follow through is very less
so Wait period is suggested
I have written Rules
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where SUNPHARMA is featured.
Frequently Asked Questions
The current price of SUNPHARMA is 1,814.00 INR — it has increased by 0.18% in the past 24 hours. Watch SUN PHARMACEUTICAL IND L stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange SUN PHARMACEUTICAL IND L stocks are traded under the ticker SUNPHARMA.
SUNPHARMA stock has fallen by −1.16% compared to the previous week, the month change is a 0.56% rise, over the last year SUN PHARMACEUTICAL IND L has showed a 45.24% increase.
We've gathered analysts' opinions on SUN PHARMACEUTICAL IND L future price: according to them, SUNPHARMA price has a max estimate of 2,450.00 INR and a min estimate of 1,600.00 INR. Watch SUNPHARMA chart and read a more detailed SUN PHARMACEUTICAL IND L stock forecast: see what analysts think of SUN PHARMACEUTICAL IND L and suggest that you do with its stocks.
SUNPHARMA reached its all-time high on Sep 30, 2024 with the price of 1,960.35 INR, and its all-time low was 2.25 INR and was reached on Jan 1, 1999. View more price dynamics on SUNPHARMA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SUNPHARMA stock is 1.18% volatile and has beta coefficient of 0.60. Track SUN PHARMACEUTICAL IND L stock price on the chart and check out the list of the most volatile stocks — is SUN PHARMACEUTICAL IND L there?
Today SUN PHARMACEUTICAL IND L has the market capitalization of 4.34 T, it has decreased by −0.19% over the last week.
Yes, you can track SUN PHARMACEUTICAL IND L financials in yearly and quarterly reports right on TradingView.
SUN PHARMACEUTICAL IND L is going to release the next earnings report on Feb 4, 2025. Keep track of upcoming events with our Earnings Calendar.
SUNPHARMA earnings for the last quarter are 12.70 INR per share, whereas the estimation was 11.99 INR resulting in a 5.97% surprise. The estimated earnings for the next quarter are 11.75 INR per share. See more details about SUN PHARMACEUTICAL IND L earnings.
SUN PHARMACEUTICAL IND L revenue for the last quarter amounts to 132.91 B INR, despite the estimated figure of 133.16 B INR. In the next quarter, revenue is expected to reach 132.92 B INR.
SUNPHARMA net income for the last quarter is 30.40 B INR, while the quarter before that showed 28.36 B INR of net income which accounts for 7.21% change. Track more SUN PHARMACEUTICAL IND L financial stats to get the full picture.
SUN PHARMACEUTICAL IND L dividend yield was 0.83% in 2023, and payout ratio reached 33.82%. The year before the numbers were 1.17% and 32.56% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 11, 2024, the company has 25.89 K employees. See our rating of the largest employees — is SUN PHARMACEUTICAL IND L on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SUN PHARMACEUTICAL IND L EBITDA is 139.13 B INR, and current EBITDA margin is 26.12%. See more stats in SUN PHARMACEUTICAL IND L financial statements.
Like other stocks, SUNPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SUN PHARMACEUTICAL IND L stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SUN PHARMACEUTICAL IND L technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SUN PHARMACEUTICAL IND L stock shows the buy signal. See more of SUN PHARMACEUTICAL IND L technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.